Financials Synthomer plc

Equities

SYNT

GB00BNTVWJ75

Specialty Chemicals

Real-time Estimate Cboe Europe 09:10:48 2023-12-04 am EST Intraday chart for Synthomer plc 5-day change 1st Jan Change
180.1 GBX -1.32% +0.67% -93.75%

Valuation

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 1 215 1 503 1 910 1 867 674 299 - -
Enterprise Value (EV) 1 1 429 1 482 2 372 1 982 1 699 973 969 894
P/E ratio 12,2x 16,5x 642x 5,34x -20,6x -0,47x -2,02x 4,73x
Yield 3,67% 3,08% 2,58% 7,51% - - 9,10% 75,8%
Capitalization / Revenue 0,75x 1,03x 1,16x 0,80x 0,26x 0,14x 0,13x 0,12x
EV / Revenue 0,88x 1,02x 1,44x 0,85x 0,66x 0,45x 0,42x 0,37x
EV / EBITDA 7,89x 8,33x 9,15x 3,79x 6,41x 6,38x 4,90x 3,79x
EV / FCF 36,4x 19,6x 17,8x 9,11x 24,5x 19,2x 19,4x 12,6x
FCF Yield 2,74% 5,09% 5,61% 11,0% 4,07% 5,21% 5,16% 7,95%
Price to Book 2,62x 2,14x 3,12x 1,83x 0,66x - - -
Nbr of stocks (in thousands) 16 994 21 237 21 242 23 366 23 367 163 564 - -
Reference price 2 71,5 70,8 89,9 79,9 28,8 1,83 1,83 1,83
Announcement Date 04/03/19 05/03/20 04/03/21 03/03/22 28/03/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 1 619 1 459 1 644 2 330 2 585 2 177 2 297 2 422
EBITDA 1 181 178 259 522 265 152 198 236
EBIT 1 142 126 190 451 171 56,2 101 137
Operating Margin 8,78% 8,62% 11,5% 19,4% 6,62% 2,58% 4,42% 5,66%
Earnings before Tax (EBT) 1 120 101 20,3 284 -47,6 -83,1 -16,5 39,9
Net income 1 99,8 84,6 3,10 209 -32,5 -48,2 1,22 36,0
Net margin 6,16% 5,80% 0,19% 8,96% -1,26% -2,21% 0,05% 1,49%
EPS 2 5,84 4,28 0,14 15,0 -1,40 -3,89 -0,90 0,39
Free Cash Flow 1 39,2 75,5 133 218 69,2 50,7 50,1 71,1
FCF margin 2,42% 5,17% 8,09% 9,34% 2,68% 2,33% 2,18% 2,94%
FCF Conversion (EBITDA) 21,7% 42,4% 51,3% 41,7% 26,1% 33,3% 25,3% 30,1%
FCF Conversion (Net income) 39,3% 89,2% 4 290% 104% - - 4 119% 197%
Dividend per Share 2 2,62 2,18 2,32 6,00 - - 0,17 1,38
Announcement Date 04/03/19 05/03/20 04/03/21 03/03/22 28/03/23 - - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period : December 2019 S1 2019 S2 2020 S1 2020 S2 2021 S1 2022 S1 2022 S2 2023 S1
Net sales 1 763 696 734 911 1 230 1 334 1 251 1 075
EBITDA 1 - 78,2 100 159 - 173 92,0 72,0
EBIT 1 74,7 51,1 68,6 121 - 132 - 23,4
Operating Margin 9,79% 7,34% 9,35% 13,3% - 9,89% - 2,18%
Earnings before Tax (EBT) 56,6 - - - - - - -
Net income - - - - - - - -
Net margin - - - - - - - -
EPS - - - - - - - -
Dividend per Share 0,80 - - - 1,74 - - -
Announcement Date 08/06/19 03/05/20 08/06/20 03/04/21 08/05/21 08/02/22 03/28/23 09/07/23
1GBP in Million
Estimates

Balance Sheet Analysis

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 214 - 462 114 1 025 674 671 595
Net Cash position 1 - 20,7 - - - - - -
Leverage (Debt/EBITDA) 1,18x - 1,78x 0,22x 3,87x 4,42x 3,39x 2,52x
Free Cash Flow 1 39,2 75,5 133 218 69,2 50,7 50,1 71,1
ROE (net income / shareholders' equity) 23,4% 15,2% 19,4% 39,8% 9,47% -1,02% 2,76% 5,60%
Shareholders' equity 1 426 557 15,9 524 -343 4 708 44,0 643
ROA (Net income/ Total Assets) 8,03% 6,65% 7,41% 14,4% - -0,17% 1,63% 2,85%
Assets 1 1 243 1 272 41,9 1 447 - 27 675 74,4 1 263
Book Value Per Share 27,3 33,0 28,8 43,6 43,5 - - -
Cash Flow per Share 2 5,73 7,31 8,74 12,6 5,72 7,48 5,02 7,84
Capex 1 58,2 69,1 53,8 82,2 90,8 80,8 85,1 92,7
Capex / Sales 3,60% 4,74% 3,27% 3,53% 3,51% 3,71% 3,70% 3,83%
Announcement Date 03/04/19 03/05/20 03/04/21 03/03/22 03/28/23 - - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
1.825GBP
Average target price
20.14GBP
Spread / Average Target
+1,003.56%
Consensus

Quarterly revenue - Rate of surprise

1st Jan change Capi.
-93.67% 378 M $
+32.18% 54 861 M $
+6.68% 43 640 M $
+16.52% 35 014 M $
-0.64% 16 700 M $
+3.00% 15 857 M $
-41.82% 14 805 M $
+35.16% 10 248 M $
-3.15% 8 799 M $
-39.99% 8 242 M $
Other Specialty Chemicals
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer